Clinical Trial Update: TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus [Phase 1]

View source ↗

Summary

Phase 1 study evaluating TRK-820 in subjects on hemodialysis with or without uremic pruritus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremic Pruritus

Drugs mentioned

• TRK-820

Snippet

Sponsor: Toray Industries, Inc | Conditions: Uremic Pruritus | Phase 1 | Status: COMPLETED